Everest Organics Ltd.

NSE: EVERESTO | BSE: 524790 | ISIN: INE334C01029 | Industry: Pharmaceuticals
| Expensive Rocket
315.1000 -5.05 (-1.58%)
BSE Apr 22, 2025 09:31 AM
Volume: 75
 

315.10
-1.58%

The US FDA completed an inspection of the Everest Organics facility in Arooor vilalge, between the 27th of Feb and the 3rd of March. The inspection resulted in one observation from the FDA, which Everest says is minor in nature, and "will address with corrective action".

Everest Organics Ltd. has gained 25.51% in the last 1 Month
More from Everest Organics Ltd.
Recommended